Ethyl 4-amino-1-piperidinecarboxylate

We are Ethyl 4-amino-1-piperidinecarboxylate CAS:58859-46-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:Ethyl 4-amino-1-piperidinecarboxylate
CAS.NO:58859-46-4
Synonyms:Ethyl 4-amino-1-piperidinecarboxylate
N-Carbethoxy-4-amino-piperidone
ethyl 4-aminopiperidine-1-carboxylate
N-Carbethoxy-4-amino-piperidone
 
Physical and Chemical Properties:
Density 1.1±0.1 g/cm3
Boiling Point 256.5±33.0 °C at 760 mmHg
Molecular Formula C8H16N2O2
Molecular Weight 172.225
Flash Point 78.3±0.0 °C
 
Specification:
Appearance:Colorless to yellow liquid
Assay:≥98.0%
Moisture:≤0.5%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Domperidone.

Ethyl 4-amino-1-piperidinecarboxylate


Related News: Characteristic APIs represented by cardiovascular, antiviral, antitumor and other categories are targeted at generic APIs with patent expiring original research drugs, which have high scientific and technological content and rich profits. They have developed in China in the past decade. The more active API segment has contributed to the rise of Huahai Pharmaceutical, Chuangnuo Pharmaceutical, and Jiangbei Pharmaceutical.4,4-dimetoxi-N, N-dimetilbutan-1-amina CAS:19718-92-4 The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it.4-Fluoro-3-nitrobenzoic acid CAS:453-71-4 The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it.2-(4-chlorophenyl)-3-methylbutyric acid CAS:2012-74-0 Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,” Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement.Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,” Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement.

Related Products
Product Name
Adenosine-5′-diphosphate disodium salt View Details
Tetramethylammonium bromide Cas:64-20-0 View Details
((5-Thiazolyl)methyl)-(4-nitrophenyl)carbonate View Details
2-Methoxybenzoic acid manufacturer decyl 2-methylprop-2-enoate manufacturer 3-Butyn-2-ol manufacturer N-methylformamide manufacturer Potassium Nitrate manufacturer